By identifying miR-668-5p as a regulator of osteoblast function that targets ZNRF3 to activate Wnt/beta-catenin signaling, our study provides a mechanistic basis for considering miR-668-5p in the development of novel strategies to mitigate chemotherapy-associated and age-related bone deterioration. This evidence concerns the gene CTNNB1 and age.